| Nov 12 |
AstraZeneca lifts 2024 outlook after Q3 beat, doubles down on US investments
|
| Nov 11 |
Home Depot earnings, YF Invest: What to Watch
|
| Nov 11 |
Will These 5 Biotech Stocks Surpass Q3 Earnings Forecasts?
|
| Nov 10 |
Wall Street Week Ahead
|
| Nov 10 |
Is AstraZeneca PLC (AZN) The Best UK Stock to Invest in Now?
|
| Nov 8 |
Disney earnings, CPI, Yahoo Finance Invest: What To Watch
|
| Nov 8 |
Stocks to watch next week: Burberry, SSE, Disney, Alibaba and AstraZeneca
|
| Nov 8 |
AstraZeneca/Amgen's Asthma Drug Aces Late-Stage Study In Patients With Chronic Rhinosinusitis
|
| Nov 8 |
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial
|
| Nov 8 |
TEZSPIRE met both co-primary endpoints in the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps
|
